1 Correction to: Drugs https://doi.org/10.1007/s40265-018-0874-x
Figure 1
The dose (mg/day) for Clonazepam which reads:
80–240
Should read:
0.25–4
Figure 1
The dose (mg/day) for Gingko biloba which reads:
0.25–4**
Should read:
80–400
Figure 1
The legend, which reads
Management of tardive dyskinesia. DRBA dopamine receptor-blocking agent, GPi globus pallidus interna, TD tardive dyskinesia, VMAT2 vesicular monoamine transporter 2. *Similar side effects but may be better tolerated than tetrabenazine. **240 mg/day used in randomized controlled trial
Should read:
Management of tardive dyskinesia. DRBA dopamine receptor-blocking agent, GPi globus pallidus interna, TD tardive dyskinesia. *Deutetrabenazine and valbenazine may be better tolerated than tetrabenazine
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Niemann, N., Jankovic, J. Correction to: Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors. Drugs 78, 609 (2018). https://doi.org/10.1007/s40265-018-0893-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40265-018-0893-7